BIOLARGO, INC. FORM OF WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISIONWarrant Agreement • May 14th, 2018 • Biolargo, Inc. • Chemicals & allied products • Delaware
THIS CERTIFIES THAT, for value received, ______________ (the “Holder”), is entitled upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date issued set forth above (the “Exercise Date”) and on or prior to the close of business on April 20, 2023 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioLargo, Inc., a Delaware corporation (the “Company”), up to ____ shares (the “Warrant Shares”) of common stock, par value, $0.00067, of the Company (the “Common Stock”). The exercise price per share of the Common Stock under this Warrant shall be $____ subject to adjustment hereunder (the “Exercise Price”).
Amendment to Convertible NoteConvertible Note Amendment • May 14th, 2018 • Biolargo, Inc. • Chemicals & allied products
THIS AMENDMENT TO CONVERTIBLE NOTE (the “Amendment”) is entered into as of January 25, 2018 (the “Effective Date”), by and among BioLargo, Inc., a Delaware corporation (“BioLargo”), and Bruce Kelber (“Kelber”), with reference to the following described “Convertible Note”:
